MCID: HYP345
MIFTS: 49

Hyper-Ige Recurrent Infection Syndrome malady

Categories: Genetic diseases, Rare diseases, Immune diseases, Skin diseases, Blood diseases, Bone diseases

Aliases & Classifications for Hyper-Ige Recurrent Infection Syndrome

About this section

Aliases & Descriptions for Hyper-Ige Recurrent Infection Syndrome:

Name: Hyper-Ige Recurrent Infection Syndrome 49 11
Job Syndrome 10 22 23 51 67 36 65
Ad-Hies 21 45 22 23 51 67
Stat3 Deficiency 21 22 23 51
Job's Syndrome 10 22 23 12
Autosomal Dominant Hyper Ige Syndrome 21 45 22
Stat3-Deficient Hyper Ige Syndrome 21 22 23
Buckley Syndrome 23 51 67
Hyperimmunoglobulin E Recurrent Infection Syndrome, Autosomal Dominant 45 67
Autosomal Dominant Hyper-Ige Syndrome 23 51
Hyperimmunoglobulin E Syndrome Type 1 51 67
Hyperimmunoglobulin E Syndrome 10 24
Hies Autosomal Dominant 45 67
Autosomal Dominant Hies 23 51
Autosomal Dominant Hyperimmunoglobulin E Recurrent Infection Syndrome 23
 
Hyper-Ige Recurrent Infection Syndrome, Autosomal Dominant 65
Autosomal Dominant Hyper-Ige Recurrent Infection Syndrome 23
Hyper-Ige Recurrent Infection Syndrome Autosomal Dominant 67
Hyper-Immunoglobulin E Syndrome, Autosomal Dominant 65
Hyperimmunoglobulin E-Recurrent Infection Syndrome 51
Autosomal Dominant Hyperimmunoglobulin E Syndrome 51
Hyper Ig E Syndrome, Autosomal Dominant 45
Hyper-Ige Syndrome Autosomal Dominant 67
Stat3 Deficient Hyper Ige Syndrome 22
Ad Hyperimmunoglobulin E Syndrome 45
Autosomal Dominant Job Syndrome 23
Job Syndrome Autosomal Dominant 45
Job-Buckley Syndrome 23
Job’s Syndrome 21

Characteristics:

Orphanet epidemiological data:

51
job syndrome:
Inheritance: Autosomal dominant; Prevalence: 1-9/1000000 (Europe),1-9/100000 (Europe); Age of onset: Infancy,Neonatal; Age of death: any age

HPO:

61
hyper-ige recurrent infection syndrome:
Onset and clinical course: infantile onset
Inheritance: autosomal dominant inheritance


Classifications:



External Ids:

OMIM49 147060
Disease Ontology10 DOID:3261
ICD1027 D82.4
MeSH36 D007589
NCIt42 C3144
Orphanet51 2314
ICD10 via Orphanet28 D82.4
UMLS via Orphanet66 C2936739, C3489795
UMLS65 C1968689, C2936739, C3887645 C3489795, more

Summaries for Hyper-Ige Recurrent Infection Syndrome

About this section
NIH Rare Diseases:45 Autosomal dominant hyper ige syndrome (ad-hies), formerly known as job syndrome, affects several body systems including the immune system. ad-hies is characterized by abnormally high levels of an immune system protein called immunoglobulin e (ige) in the blood.  signs and symptoms may include recurrent infections (e.g., pneumonia, skin infections), eczema, and occasionally bone and tooth abnormalities. the eczema and skin infections may cause rashes, blisters, collections of pus (abscesses), open sores, and scaling of the skin. some cases of ad-hies are caused by mutations in the stat3 gene. in other cases, the cause is unknown. last updated: 7/14/2015

MalaCards based summary: Hyper-Ige Recurrent Infection Syndrome, also known as job syndrome, is related to hyper-ige recurrent infection syndrome, autosomal recessive and hyper ige syndrome, and has symptoms including skin ulcer, atelectasis and pruritus. An important gene associated with Hyper-Ige Recurrent Infection Syndrome is STAT3 (Signal Transducer And Activator Of Transcription 3), and among its related pathways are IL27-mediated signaling events and Th17 Differentiation Pathway. Affiliated tissues include bone, skin and lung, and related mouse phenotypes are hematopoietic system and immune system.

Genetics Home Reference:23 Autosomal dominant hyper-IgE syndrome (AD-HIES), also known as Job syndrome, is a condition that affects several body systems, particularly the immune system. Recurrent infections are common in people with this condition. Affected individuals tend to have frequent bouts of pneumonia, which are caused by certain kinds of bacteria that infect the lungs and cause inflammation. These infections often result in the formation of air-filled cysts (pneumatoceles) in the lungs. Recurrent skin infections and an inflammatory skin disorder called eczema are also very common in AD-HIES. These skin problems cause rashes, blisters, accumulations of pus (abscesses), open sores, and scaling.

OMIM:49 Hyper-IgE recurrent infection syndrome is a primary immunodeficiency disorder characterized by chronic eczema,... (147060) more...

UniProtKB/Swiss-Prot:67 Hyperimmunoglobulin E recurrent infection syndrome, autosomal dominant: A rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eczema, recurrent Staphylococcal infections, increased serum IgE, eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.

GeneReviews summary for NBK25507

Related Diseases for Hyper-Ige Recurrent Infection Syndrome

About this section

Graphical network of the top 20 diseases related to Hyper-Ige Recurrent Infection Syndrome:



Diseases related to hyper-ige recurrent infection syndrome

Symptoms for Hyper-Ige Recurrent Infection Syndrome

About this section

Symptoms by clinical synopsis from OMIM:

147060

Clinical features from OMIM:

147060

Symptoms:

 51 (show all 38)
  • anomalies of skin, subcutaneous tissue and mucosae
  • chronic skin infection/ulcerations/ulcers/cancrum
  • cutaneous rash
  • eczema
  • pruritus/itching
  • ground-glass/reticular/alveolar/interstitial lung/pulmonary opacity
  • atelectasia/pulmonary collapse
  • repeat respiratory infections
  • anomalies of the immunitary system
  • immunodeficiency/increased susceptibility to infections/recurrent infections
  • autosomal dominant inheritance
  • frontal bossing/prominent forehead
  • face/facial anomalies
  • deepset eyes/enophthalmos
  • broad nose/nasal bridge
  • gingivitis
  • cleft palate without cleft lip/submucosal cleft palate/bifid uvula
  • anomalies of teeth and dentition
  • delayed dentition/eruption of teeth/lack of eruption of teeth
  • chronic/relapsing otitis
  • scoliosis
  • follicular/erythematous/edematous papules/milium
  • hair and scalp anomalies
  • dysplastic/thick/grooved fingernails
  • onyxis/paronyxis/ungual inflammation
  • cough
  • osteoporosis/osteopenia/demineralisation/osteomalacia/rickets
  • mutiple fractures/bone fragility
  • hyperextensible joints/articular hyperlaxity
  • eosinophils anomalies/hypereosinophilia
  • craniostenosis/craniosynostosis/sutural synostosis
  • cellulitis/panniculitis/pseudocellulitis/inflammation of subcutaneous tissue
  • vesicles/bullous/exsudative lesions/bullous/cutaneous/mucosal detachment
  • arterial aneurism (excluding aorta)
  • osteomyelitis/osteitis/periostitis/spondylodisciitis
  • lymphoma
  • autosomal recessive inheritance
  • fever/chilling

HPO human phenotypes related to Hyper-Ige Recurrent Infection Syndrome:

(show all 43)
id Description Frequency HPO Source Accession
1 skin ulcer hallmark (90%) HP:0200042
2 atelectasis hallmark (90%) HP:0100750
3 pruritus hallmark (90%) HP:0000989
4 skin rash hallmark (90%) HP:0000988
5 reduced bone mineral density typical (50%) HP:0004349
6 recurrent fractures typical (50%) HP:0002757
7 scoliosis typical (50%) HP:0002650
8 frontal bossing typical (50%) HP:0002007
9 abnormality of eosinophils typical (50%) HP:0001879
10 paronychia typical (50%) HP:0001818
11 joint hypermobility typical (50%) HP:0001382
12 abnormality of the fingernails typical (50%) HP:0001231
13 delayed eruption of teeth typical (50%) HP:0000684
14 deeply set eye typical (50%) HP:0000490
15 otitis media typical (50%) HP:0000388
16 abnormality of the nose typical (50%) HP:0000366
17 gingivitis typical (50%) HP:0000230
18 cleft palate typical (50%) HP:0000175
19 cellulitis occasional (7.5%) HP:0100658
20 abnormal blistering of the skin occasional (7.5%) HP:0008066
21 abnormality of temperature regulation occasional (7.5%) HP:0004370
22 osteomyelitis occasional (7.5%) HP:0002754
23 lymphoma occasional (7.5%) HP:0002665
24 aneurysm occasional (7.5%) HP:0002617
25 craniosynostosis occasional (7.5%) HP:0001363
26 prominent forehead HP:0011220
27 persistence of primary teeth HP:0006335
28 recurrent sinopulmonary infections HP:0005425
29 increased ige level HP:0003212
30 recurrent fungal infections HP:0002841
31 recurrent fractures HP:0002757
32 recurrent staphylococcus aureus infections HP:0002726
33 scoliosis HP:0002650
34 frontal bossing HP:0002007
35 eosinophilia HP:0001880
36 joint hypermobility HP:0001382
37 craniosynostosis HP:0001363
38 eczematoid dermatitis HP:0000976
39 osteopenia HP:0000938
40 wide nose HP:0000445
41 hypertelorism HP:0000316
42 coarse facial features HP:0000280
43 high palate HP:0000218

Drugs & Therapeutics for Hyper-Ige Recurrent Infection Syndrome

About this section

Drugs for Hyper-Ige Recurrent Infection Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 116)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CilostazolapprovedPhase 410073963-72-12754
Synonyms:
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
73963-72-1
89332-50-3
AC-4334
AC1L1EE2
BRD-K67017579-001-04-2
BRD-K67017579-001-05-9
BRD-K67017579-001-07-5
BRD-K67017579-001-13-3
BRN 3632107
BSPBio_002759
C 0737
C045645
C0737_SIGMA
C20H27N5O2
CHEBI:31401
CHEMBL799
CID2754
CL23867
CPD000058428
Cilostazol
Cilostazol (JP15/USAN/INN)
Cilostazol [INN:JAN]
Cilostazole
Cilostazolum
Cilostazolum [INN-Latin]
D01896
DB01166
EU-0100218
HMS1922N15
HMS2093M14
KBio3_002259
KBioGR_001184
 
LS-142693
Lopac-C-0737
Lopac0_000218
MLS000028470
MLS000758281
MLS000759507
MLS001076067
MLS002153891
MolPort-001-758-007
NCGC00015207-01
NCGC00015207-02
NCGC00015207-06
NCGC00015207-10
NCGC00022153-02
NCGC00022153-04
NCGC00022153-05
NCGC00022153-06
NCGC00022153-07
OPC 13013
OPC 21
OPC-13013
OPC-21
Otsuka brand of cilostazol
Pletaal
Pletal
Pletal (TN)
Pletal, Cilostazol
S1294_Selleck
SAM001246734
SAM001247085
SMR000058428
SPBio_001256
SPECTRUM1505230
Spectrum2_001118
Spectrum3_001170
Spectrum4_000772
Spectrum5_001762
TL8005113
Tocris-1692
UNII-N7Z035406B
ZINC01552174
cilostazol
2
AspirinapprovedPhase 4102950-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
3
HaloperidolapprovedPhase 4, Phase 113652-86-83559
Synonyms:
1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine
4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
5-21-02-00377 (Beilstein Handbook Reference)
52-86-8
AB00052008
AC-19691
AC1L1G7K
AC1Q77Z0
AKOS000280660
ALDO
Aldo
Aloperidin
Aloperidol
Aloperidolo
Aloperidolo [DCIT]
Aloperidolo [Italian]
Aloperidon
Apo-Haloperidol
BIDD:GT0128
BPBio1_000144
BPBio1_001231
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRN 0331267
BSPBio_000130
BSPBio_002096
Bio-0705
Biomol-NT_000035
Bioperidolo
Brotopon
C01814
C21H23ClFNO2
CAS-52-86-8
CCRIS 1630
CHEBI:5613
CHEMBL54
CID3559
D00136
D006220
DB00502
DivK1c_000654
Dozic
Dozix
EINECS 200-155-6
EU-0100583
Einalon S
Eukystol
Fortunan
Galoperidol
H 1512
H0912
H1512_SIGMA
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
HMS502A16
HSDB 3093
Haldol
Haldol Decanoate
Haldol La
Haldol Solutab
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol
Haloperidol (JP15/USP)
Haloperidol (JP15/USP/INN)
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidol [USAN:INN:BAN:JAN]
Haloperidolum
Haloperidolum [INN-Latin]
Halopidol
Halopoidol
Halosten
I14-13404
I14-14165
 
IDI1_000654
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
Keselan
L000288
LS-48311
Lealgin Compositum
Lealgin compositum
Linton
Lopac-H-1512
Lopac0_000583
MLS000028450
MLS001146904
McN-JR-1625
Mixidol
MolPort-000-883-311
NCGC00015500-01
NCGC00015500-02
NCGC00015500-06
NCGC00015500-14
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NINDS_000654
NSC 170973
NSC 615296
NSC170973
NSC615296
Novo-Peridol
Oprea1_509923
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Prestwick_250
Probes1_000255
Probes2_000296
QTL1_000042
R 1625
R-1625
S1920_Selleck
SMR000058303
SPBio_001236
SPBio_002069
SPECTRUM1500325
Serenace
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
Spectrum_000861
Tocris-0931
UNII-J6292F8L3D
Ulcolind
Uliolind
Vesalium
WLN: T6NTJ A3VR DF& DQ DR DG
cMAP_000037
gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone
haloperidol
4
Olanzapineapproved, investigationalPhase 4379132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
LY-170053
 
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapine pamoate
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
5
FluphenazineapprovedPhase 41669-23-83372
Synonyms:
1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine
1-(2-Hydroxyethyl)-4-[3-(trifluoromethyl-10-phenothiazinyl)propyl]piperazine
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)- (9CI)
10-(3'-(4"-(beta-Hydroxyethyl)-1"-piperazinyl)-propyl)-3-trifluoromethylphenothiazine
10-(3'-(4''-(beta-Hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine
10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine
10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine
2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethanol
2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-pipe razinyl)propyl)phenothiazine
2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol dihydrochloride
4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol
4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol
4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-Piperazineethanol
4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol
4-[3-(2-Trifluoromethyl-10-phenothiazyl)-propyl]-1-piperazineethanol
47646-09-3
69-23-8
AB00053587
AC1L1FSB
AKOS001659031
Apo-Fluphenazine
BIDD:PXR0184
BPBio1_000352
BPBio1_001187
BRD-K55127134-001-01-7
BRD-K55127134-300-05-4
BSPBio_000320
BSPBio_003100
Bio-0775
Biomol-NT_000023
C07010
C22H26F3N3OS
CAS-146-56-5
CHEBI:136842
CHEBI:5123
CHEMBL726
CID3372
ChemDiv1_024180
D005476
D07977
DB00623
Dapotum
DivK1c_000511
EINECS 200-702-9
Elinol
FLUPHENAZINE
Flufenazin
Flufenazina
Flufenazina [DCIT]
Fluorfenazine
Fluorophenazine
Fluorphenazine
Fluphenazin
Fluphenazine (INN)
Fluphenazine Decanoate
Fluphenazine Hcl
Fluphenazine [INN:BAN]
Fluphenazine decanoate
Fluphenazine dihydrochloride
Fluphenazine enanthate
Fluphenazine hydrochloride
Fluphenazinum
Fluphenazinum [INN-Latin]
Fluphénazine
Ftorphenazine
 
HMS2089C16
HMS655L02
HSDB 3334
Hydrochloride, Fluphenazine
IDI1_000511
KBio1_000511
KBio2_000769
KBio2_002386
KBio2_003337
KBio2_004954
KBio2_005905
KBio2_007522
KBio3_002320
KBio3_002865
KBioGR_001375
KBioGR_002386
KBioSS_000769
KBioSS_002391
L000257
LS-112565
Lopac-F-4765
Lopac0_000555
Modecate
Moditen (TN)
Moditen (Tabl or elixir)
Moditen Enanthate
Moditen Hcl
MolPort-001-727-938
NCGC00015436-01
NCGC00015436-02
NCGC00015436-03
NCGC00015436-08
NCGC00024429-03
NCGC00024429-04
NINDS_000511
NSC 62323
NSC62323
Pacinol
Permitil Concentrate
Phthorphenazine
Prestwick0_000320
Prestwick1_000320
Prestwick2_000320
Prestwick3_000320
Probes1_000254
Probes2_000295
Prolixin
Prolixin Concentrate
Prolixin Enanthate
Prolixine
S94
SPBio_001277
SPBio_002539
SQ 4918
SR-01000003048-5
STK050763
Sevinol
Siqualine
Siqualon
Spectrum2_001199
Spectrum3_001420
Spectrum4_000828
Spectrum5_001536
Spectrum_000289
Triflumethazine
UNII-S79426A41Z
Vespazine
Yespazine
cMAP_000035
nchembio873-comp68
6
PimozideapprovedPhase 4112062-78-416362
Synonyms:
1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H- benzimidazol-2-one
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
2062-78-4
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
5-24-02-00367 (Beilstein Handbook Reference)
AB00052215
AC1L27SR
AC1Q4M09
AC1Q4NM9
ASTA Medica Brand of Pimozide
Antalon
BCBcMAP01_000043
BIDD:GT0435
BPBio1_000304
BRD-K01292756-001-06-0
BRN 0729089
BSPBio_000276
BSPBio_001439
BSPBio_002941
C07566
C28H29F2N3O
CAS-2062-78-4
CCRIS 9172
CHEBI:8212
CHEMBL1423
CID16362
D00560
D010868
DB01100
DivK1c_000386
EINECS 218-171-7
EU-0100946
HMS1568N18
HMS1791H21
HMS1921H19
HMS1989H21
HMS2089C11
HMS2092F09
HMS501D08
Halomonth
IDI1_000386
Janssen Brand of Pimozide
KBio1_000386
KBio2_000925
KBio2_003493
KBio2_006061
KBio3_002441
KBioGR_000720
KBioSS_000925
L000494
LS-33236
Lopac-P-1793
Lopac0_000946
MLS000028410
 
MLS001077311
MLS002702058
McN-JR 6238
McN-JR-6238
MolPort-001-736-597
NCGC00015802-01
NCGC00015802-02
NCGC00015802-04
NCGC00015802-15
NCGC00016601-01
NCGC00022282-03
NCGC00024888-01
NCGC00024888-02
NCGC00024888-03
NCGC00024888-04
NCGC00024888-05
NCGC00024888-06
NCGC00024888-07
NCIMech_000356
NINDS_000386
NSC 170984
NSC170984
Neoperidole
Opiran
Orap
Orap (TN)
Orap forte
P 1793
P1793_SIGMA
Pharmascience Brand of Pimozide
Pimozida
Pimozida [INN-Spanish]
Pimozide
Pimozide (JAN/USP/INN)
Pimozide [USAN:INN:BAN:JAN]
Pimozidum
Pimozidum [INN-Latin]
Prestwick0_000308
Prestwick1_000308
Prestwick2_000308
Prestwick3_000308
Prestwick_395
Primozida
Primozida [INN-Spanish]
R 6238
R-6238
R6238
SMP1_000241
SMR000058385
SPBio_001211
SPBio_002495
SPECTRUM1501134
Spectrum2_001026
Spectrum3_001451
Spectrum4_000420
Spectrum5_001308
Spectrum_000445
Tocris-0937
UNII-1HIZ4DL86F
WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF
pimozida
pimozide
7
SulpirideapprovedPhase 42315676-16-15355
Synonyms:
( inverted question mark)-Sulpiride
(+-)-Sulpiride
(+/-)-Sulpiride
(?)-Sulpiride
(RS)-(+/-)-sulpiride
15676-16-1
23672-07-3
5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide
5-22-08-00105 (Beilstein Handbook Reference)
AC-12181
AC1L1K62
AKOS004912732
Abilit
Aiglonyl
Alimoral
Allphar Brand of Sulpiride
Almirall Brand of Sulpiride
Areu Brand of Sulpiride
Arminol
BPBio1_000233
BPBio1_000463
BPBio1_001255
BRD-A55272860-001-03-9
BRD-A55272860-001-04-7
BRN 0494008
BSPBio_000211
Bio-0717
Biomol-NT_000037
Biomol-NT_000162
C15H23N3O4S
CCRIS 4248
CHEMBL26
CID5355
Calmoflorine
Centrum Brand of Sulpiride
Championyl
Coolspan
D01226
D013469
DB00391
Darleton
Deponerton
Desisulpid
Desitin Brand of Sulpiride
Desmenat
Digton
DivK1c_000278
Dobren
Dogmatil
Dogmatyl
Dogmatyl (TN)
Dolmatil
Dolorgiet Brand of Sulpiride
Dresent
EINECS 239-753-7
EU-0001755
EU-0101050
Eglonil
Eglonyl
Ekilid
Enimon
Equilid
Erempharma Brand of Sulpiride
Eusulpid
Fardalan
Fidelan
Fumouzer Brand of Sulpiride
Guastil
HMS1568K13
HMS500N20
Hennig Brand of Sulpiride
Hexal Brand of Sulpiride
Hoechst Brand of Sulpiride
Hormosan Brand of Sulpiride
I06-0054
IDI1_000278
Isnamide
KBio1_000278
Krewel Brand of Sulpiride
Kylistro
L000579
LS-20058
LS-20059
Lebopride
Levobren
Levopraid
Levosulpirida
Levosulpirida [INN-Spanish]
 
Levosulpiride
Levosulpiride [INN]
Levosulpiridum
Levosulpiridum [INN-Latin]
Lisopiride
Lopac0_001050
MLS000069434
MLS001306443
Magnetic resonance imaging sulpiride
Mariastel
Meresa
Miradol
Mirbanil
Misulvan
MolPort-002-070-475
N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide
N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
NCGC00015966-04
NCGC00015966-08
NCGC00024852-02
NCGC00024852-03
NCGC00024852-04
NCGC00024852-05
NINDS_000278
Neogama
Norestran
Normum
Nufarol
Omiryl
Omperan
Oprea1_602476
Ozoderpin
Pharmacia Brand of Sulpiride
Pontiride
Prestwick0_000056
Prestwick1_000056
Prestwick2_000056
Prestwick3_000056
Prestwick_431
Psicocen
Psicofarma Brand of Sulpiride
Pyrikappl
Pyrkappl
R. D. 1403
R.D. 1403
RD 1403
RV-12309
Restful
Rosemont Brand of Sulpiride
S 8010
S-(-)-Sulpiride
S8010_SIGMA
SMR000038923
SPBio_002132
STK368596
Sanofi Synthelabo Brand of Sulpiride
Sanofi-Synthelabo Brand of Sulpiride
Sernevin
Splotin
Spyfarma Brand of Sulpiride
Stamonevrol
Sulp
Sulperide
Sulpirid
Sulpirida
Sulpirida [INN-Spanish]
Sulpiride (JP15/USAN/INN)
Sulpiride [USAN:INN:BAN:JAN]
Sulpiridum
Sulpiridum [INN-Latin]
Sulpitil
Sulpivert
Sulpor
Sulpride
Sulpyrid
Suprium
Sursumid
Synedil
Tepavil
Uriach Brand of Sulpiride
Valirem
Vertigo Meresa
Vertigo-Meresa
Zemorcon
nchembio873-comp17
sulpiride
vertigo neogama
vertigo-neogama
8
ZiprasidoneapprovedPhase 4140146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone Hydrochloride
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
9
ThioridazineapprovedPhase 41050-52-25452
Synonyms:
(+-)-Thioridazine
10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine
10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine
10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine
2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine
3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine
50-52-2
57129-06-3
AB00053553
AC1L1KDN
AI3-51923
Aldazine
BPBio1_000325
BPBio1_001175
BSPBio_000295
BSPBio_002030
Biomol-NT_000017
C21H26N2S2
CHEBI:9566
CHEMBL479
CID5452
D00373
DB00679
DivK1c_000066
EINECS 200-044-2
HMS2090J04
HSDB 3189
IDI1_000066
KBio1_000066
KBio2_001546
KBio2_002308
KBio2_004114
KBio2_004876
KBio2_006682
KBio2_007444
KBio3_001530
KBio3_002788
KBioGR_000791
KBioGR_002308
KBioSS_001546
KBioSS_002310
L001321
LS-105605
Lopac0_001252
Mallorol
Malloryl
Meleril
Mellaril
Mellaril (*Hydrochloride*)
Mellaril Hydrochloride
 
Mellaril-S
Mellaril-S (TN)
Mellarit
Mellerets
Mellerette
Melleretten
Melleril
Melleril (liquid)
Melleryl
Metlaril
NCGC00016059-10
NCGC00089809-02
NCGC00089809-03
NINDS_000066
Novoridazine
Orsanil
Prestwick0_000078
Prestwick1_000078
Prestwick2_000078
Prestwick3_000078
Ridazin
Ridazine
SPBio_001483
SPBio_002216
Sonapax
Sonapax Hydrochloride
Spectrum2_001332
Spectrum3_000585
Spectrum4_000356
Spectrum5_001062
Spectrum_001066
Stalleril
TP-21
Thioridazin
Thioridazine (USP/INN)
Thioridazine Chloride
Thioridazine Hcl
Thioridazine Hcl Intensol
Thioridazine Hydrochloride
Thioridazine [USAN:INN:BAN]
Thioridazine prolongatum
Thioridazine, Prolongatum
Thioridazine, prolongatum
Thioridazinum
Thioridazinum [INN-Latin]
Thioxidazine
Thoridazine Hydrochloride
Thoridazine hydrochloride
Tioridazin
Tioridazina
Tioridazina [INN-Spanish]
UNII-N3D6TG58NI
cMAP_000015
dl-Thioridazine
thioridazine
10
DopamineapprovedPhase 4, Phase 1308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
11
Risperidoneapproved, investigationalPhase 4, Phase 1477106266-06-25073
Synonyms:
106266-06-2
3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydro-pyrido[
3-(2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-[2-[4-(6-fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,
3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
AB00514010
AC-1306
AC1L1JJU
BIDD:GT0262
BRD-K53857191-001-04-5
BRN 4891881
Belivon
Bio-0092
Buspirone
C23H27FN4O2
CAS-106266-06-2
CHEBI:8871
CHEMBL85
CID5073
CPD000466323
Consta, Risperdal
D00426
D018967
DB00734
EU-0101074
HMS1571M19
HMS2051H07
HMS2089C22
HSDB 7580
I01-1156
Jsp000573
KS-1106
L000510
LS-134196
Lopac-R-118
MLS000759429
MLS001165758
MLS001424081
MolPort-002-885-858
NCGC00015883-01
 
NCGC00015883-02
NCGC00015883-03
NCGC00094352-01
NCGC00094352-02
NCGC00094352-03
NCGC00179257-01
Prestwick0_001029
Prestwick1_001029
R 62 766
R 64 766, Risperdal, Risperidone
R 64,766
R 64766
R-118
R-64,766
R-64-766
R-64766
R64,766
R64766
Rispen
Risperdal
Risperdal (TN)
Risperdal Consta
Risperdal M-Tab
Risperdal M-tab
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Risperidone (JAN/USAN/INN)
Risperidone (RIS)
Risperidone M-tab
Risperidone [USAN:BAN:INN]
Risperidone, placebo
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
S1615_Selleck
SAM001246595
SMR000466323
SPBio_003078
STK646402
Sequinan
Spiron
TL8000230
UNII-L6UH7ZF8HC
risperdone
risperidone
12
PerphenazineapprovedPhase 48358-39-94748
Synonyms:
.gamma.-[4-(.beta.-Hydroxyethyl)piperazin-1-yl]propyl-2-chlorophenothiazine
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina
1',1-(2-Idrossietil)-4,3-(2-cloro-10-fenotiazil)propilpiperazina [Italian]
1-(2-Hydroxyethyl)-4-(3-(2-chloro-10-phenothiazinyl)propyl)piperazine
1-(2-Hydroxyethyl)-4-[3-(2-chloro-10-phenothiazinyl)propyl]piperazine
1-Piperazineethanol, 4-[3-(2-chlorophenothiazin-10-yl)propyl]-, trihydrochloride
2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol
2-Chloro-10-(3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine
2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-Chloro-10-3-(1-(2-hydroxyethyl)-4-piperazinyl)propyl phenothiazine
2-Chloro-10-3-[1-(2-hydroxyethyl)-4-piperazinyl]propyl phenothiazine
2-Chloro-10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazine
2-[4-[3-(2-Chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol
2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine
2-{4-[3-(2-Chloro-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol
2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol
4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol
4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol
58-39-9
AB00052390
AC-12196
AC1L1IVB
AI3-50151
AKOS000664046
Apo-Perphenazine
BAS 00139131
BIDD:GT0150
BPBio1_000188
BRD-K10995081-001-05-5
BSPBio_000170
BSPBio_002376
C07427
C21H26ClN3OS
CAS-58-39-9
CHEBI:8028
CHEMBL567
CID4748
CPD000058180
Chlorperphenazine
Chlorpiprazine
D00503
D010546
DB00850
Decentan
DivK1c_000880
EINECS 200-381-5
EU-0072164
EU-0100930
Emesinal
Etaperazin
Etaperazine
Ethaperazine
Etrafon-A
Etrafon-Forte
F-Mon
F-mon
Fentazin
HMS1568I12
HMS1922M14
HMS2093M15
HMS502L22
HSDB 3379
I06-1508
IDI1_000880
KBio1_000880
KBio2_002090
KBio2_004658
KBio2_007226
 
KBio3_001596
KBioGR_001445
KBioSS_002090
L000919
LS-112185
Lopac-P-6402
Lopac0_000930
MLS000069637
MLS001146929
MolPort-001-727-942
NCGC00015826-01
NCGC00015826-02
NCGC00015826-03
NCGC00015826-06
NCGC00015826-10
NCGC00024092-03
NCGC00024092-04
NCGC00024092-05
NCGC00024092-06
NINDS_000880
NSC 150866
NSC150866
Oprea1_603835
P 6402
P6402_SIGMA
PZC
Perfenazina
Perfenazina [INN-Spanish]
Perfenazina [Italian]
Perfenazine
Perphenan
Perphenazin
Perphenazine
Perphenazine (JP15/USP/INN)
Perphenazine [INN:BAN:JAN]
Perphenazine [Trilafon]
Perphenazine enanthate
Perphenazine heptanoate
Perphenazine maleate
Perphenazinum
Perphenazinum [INN-Latin]
Perphénazine
Prestwick0_000125
Prestwick1_000125
Prestwick2_000125
Prestwick3_000125
Prestwick_536
SAM002264637
SCH-3940
SMR000058180
SPBio_001603
SPBio_002109
SPECTRUM1503934
SR-01000000137-4
STK019818
STOCK1S-21551
Sch 3940
Spectrum2_001602
Spectrum3_000758
Spectrum4_000843
Spectrum5_001493
Spectrum_001610
Thilatazin
Tranquisan
Trifaron
Trilafon
Trilifan
Triphenot
UNII-FTA7XXY4EZ
WLN: T C666 BN ISJ EG B3- AT6N DNTJ D2Q
gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine
nchembio873-comp26
perphenazine
13
Clopidogrelapproved, nutraceuticalPhase 4717120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel Bisulfate
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
 
IDI1_000787
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
14Anti-Asthmatic AgentsPhase 4, Phase 12796
15Respiratory System AgentsPhase 4, Phase 13931
16Phosphodiesterase InhibitorsPhase 41062
17Protective AgentsPhase 45651
18Fibrinolytic AgentsPhase 41567
19Neuroprotective AgentsPhase 41376
20Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 118510
21Phosphodiesterase 3 InhibitorsPhase 4113
22Platelet Aggregation InhibitorsPhase 41935
23Purinergic P2Y Receptor AntagonistsPhase 4654
24Purinergic P2 Receptor AntagonistsPhase 4656
25Neurotransmitter AgentsPhase 4, Phase 2, Phase 114795
26Vasodilator AgentsPhase 42926
27Bronchodilator AgentsPhase 42377
28Psychotropic DrugsPhase 4, Phase 3, Phase 15501
29Quetiapine FumaratePhase 4403111974-72-2
30Tranquilizing AgentsPhase 4, Phase 3, Phase 13597
31sultopridePhase 446
32Dopamine AgentsPhase 4, Phase 13084
33ClopenthixolPhase 46
34Antipsychotic AgentsPhase 4, Phase 12130
35Dopamine AntagonistsPhase 4, Phase 1927
36Central Nervous System DepressantsPhase 4, Phase 3, Phase 110016
37Haloperidol decanoatePhase 4, Phase 1136
38Fluphenazine depotPhase 416
39Fluphenazine enanthatePhase 416
40
Posaconazoleapproved, investigationalPhase 349171228-49-2147912
Synonyms:
1-((1S,2S)-1-Ethyl-2-hydroxypropyl)-4-{4-[4-(4-{[(5S,3R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazolylmethyl)oxolan-3-yl]methoxy}phenyl)piperazinyl]phenyl}-1,2,4-triazolin-5-one
171228-49-2
177571-33-4
4-(p-(4-(p-(((3R,5R)-5-(2,4-Difluorophenyl)tetrahydro-5-(1H-1,2,4-triazol-1-ylmethyl)-3-furyl)methoxy)phenyl)-1-piperazinyl)phenyl)-1-((1S,2S)-1-ethyl-2-hydroxypropyl)-delta(sup 2)-1,2,4-triazolin-5-one
4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one
4-[4-[4-[4-[[(5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one
AC-1350
AC1L3W34
AC1LAHLQ
AKOS005145917
CHEBI:434337
CHEMBL1397
CHEMBL371938
CHEMBL371939
CID10532764
CID11520437
CID11542142
CID147912
CID468595
D02555
DB01263
 
HSDB 7421
LS-186118
LS-186988
LS-187630
MolPort-006-666-426
Noxafil
Noxafil (TN)
Noxafil, Posaconazole
Posaconazole
Posaconazole (USAN/INN)
Posaconazole SP
Posaconazole [USAN:INN:BAN]
Posaconazole in combination with MGCD290
Posanol
S1257_Selleck
SCH-56592
SCH56592
SID144207169
Sch 56592
Spriafil
UNII-6TK1G07BHZ
X2N
posaconazole
41
Miconazoleapproved, investigationalPhase 3, Phase 2302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
42
Doxycyclineapproved, investigationalPhase 3219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
43
Pregabalinapproved, illicit, investigationalPhase 3340148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
44
LidocaineapprovedPhase 31103137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Afterburn
Akten
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bikini Zone Medicated
Bikini Zone Medicated Creme
Bio-0767
Bio-scriptives Lidum
Bio-scriptives Lidum Hemorroidal (anorectal)
Bio-scriptives Lidum Topical Analgesic
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
Burn Relief Leader
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Comfortcaine
Cuivasil
Curacaine Transdermal Corporation
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
Derma Numb
DermaFlex
Desert Harvest Releveum
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Dr. Numb
Dr. Richs Numbing
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gigi Anesthetic Numbing
Gravocain
H-releve Hemorrhoidal
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
Hawaiian Tropic
Hush Anesthetic
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
LS-805
Lanabiotic
 
Laryng-o-jet
Leostesin
Lida-Mantle
Lidall
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine 4% Cream
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Hydrochloride
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocaine hydrochloride
Lidocainum
Lidocainum [INN-Latin]
Lidocare Mist
Lidocaton
Lidocream 4
Lidocream 5
Lidoderm
Lidoderm 5
Lidoject-1
Lidoject-2
Lifestyles Epic Male Genital Desensitizer
Lignocaine
Lignocainum
Lingocaine
Lmx4
Lmx5
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Numb Master Topical Anesthetic
Numb Nuts
Ocean Potion Instant Burn Relief Ice
Octocaine
Octocaine-100
Octocaine-50
Plum Smooth Plumb Numb Gelee
Premjact Male Desensitizer Pound International
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Recticare
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Simplicity Desensitizing
Simply Numb Endure
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Sole Serum
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Walgreens Aloe Vera Pain Relieving
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocaine-mpf
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zcaine Fast Acting Anesthetic
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
45Anti-Bacterial AgentsPhase 3, Phase 29140
46Antibiotics, AntitubercularPhase 35971
47Antitubercular AgentsPhase 31061
48Hormone AntagonistsPhase 310002
49Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 39988
50Antiparasitic AgentsPhase 3, Phase 21854

Interventional clinical trials:

(show all 47)
idNameStatusNCT IDPhase
1Efficacy and Safety of Adjunctive Cilostazol in Acute Myocardial Infarction PatientsRecruitingNCT01261832Phase 4
2Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsActive, not recruitingNCT02307396Phase 4
3Posaconazole to Treat Invasive Fungal InfectionsCompletedNCT00033982Phase 3
4Antibiotic Treatment of Gulf War Veterans' IllnessesCompletedNCT00007735Phase 3
5Cognitive Behavior Therapy for Work Success in Veterans With Mental Illness: A Pre-post Efficacy StudyRecruitingNCT01918774Phase 3
6Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer PainActive, not recruitingNCT02240199Phase 3
7Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency DiseasesRecruitingNCT01852370Phase 1, Phase 2
8CAMB/MAT2203 in Patients With Mucocutaneous CandidiasisRecruitingNCT02629419Phase 2
9Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 RiskActive, not recruitingNCT01720225Phase 2
10Combination Study of Cytarabine and Tosedostat in Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndromes (MDS)Active, not recruitingNCT01636609Phase 1, Phase 2
11Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) SyndromeTerminatedNCT00527878Phase 2
12Omalizumab to Treat Hyper-IgE (Job's) SyndromeCompletedNCT00260702Phase 1
13Diagnostic Effectiveness of Virtual BronchoscopyCompletedNCT00001515Phase 1
14Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy VolunteersEnrolling by invitationNCT01259973Phase 1
15Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related DisordersCompletedNCT00005933
16Sleep Disorders Management, Health and Safety in PoliceCompletedNCT00207285
17Fire Fighter Fatigue Management Program: Operation Healthy SleepCompletedNCT01988129
18Comprehensive Police Fatigue Management ProgramCompletedNCT00246051
19Effectiveness of Physical Therapy Program to Treat Rotator Cuff Disorders Among Nursing ProfessionalsCompletedNCT01465932
20Effectiveness of an Intervention for Prevention and Treatment of Burnout in Primary CareCompletedNCT01870154
21Health Protection & Promotion for Oregon Correctional OfficersCompletedNCT02098603
22Level of Burn Out of Surgical Residents Working in All Hospitals of LahoreCompletedNCT02206139
23Level of Burn Out of Surgical Residents Working in Government Hospitals of LahoreCompletedNCT02204592
24Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone ConsultationCompletedNCT00129701
25The Effects of Work Schedule and Sleep Patterns on Caregivers' HealthCompletedNCT01443156
26Stress Free Now, a Mind-body Reduction Program for NursesCompletedNCT01796054
27Inflammation and Glycation in a General Adult PopulationCompletedNCT01796184
28Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent InfectionRecruitingNCT00006150
29Study of Mycobacterial InfectionsRecruitingNCT00018044
30Collection of Lung Fluid and Tissue Samples for ResearchRecruitingNCT00471250
31Detection and Characterization of Infections and Infection SusceptibilityRecruitingNCT00404560
32Human Immunity Against Staphylococcus Aureus Skin InfectionRecruitingNCT02262819
33Studies of Skin Microbes in Healthy People and in People With Skin ConditionsRecruitingNCT00605878
34Occupational Status and Hematological DiseaseRecruitingNCT02057185
35Study of Autoimmune Lymphoproliferative Syndrome (ALPS)RecruitingNCT00001350
36Effectiveness Study of Integrative Treatment for Pediatric Community Acquired PneumoniaRecruitingNCT02362906
37Influence of Light Therapy on Confusion in Patients at the Intensive Care UnitRecruitingNCT01343433
38International Guillain-Barré Syndrome Outcome StudyRecruitingNCT01582763
39Nursing Therapeutics Education and Heart Failure (HF): a Study ProtocolRecruitingNCT02425488
40Percutaneous Transforaminal Endoscopic Discectomy vs. Open Microdiscectomy for Lumbar Disc Herniation (PTED-study)RecruitingNCT02602093
41Assessment of Quality of Global and Sexual Life and Impact of Surgical and Non Surgical Vaginal Aplasia in Patients With a Rokitansky SyndromeActive, not recruitingNCT01911884
42Genetic Analysis of Immune DisordersEnrolling by invitationNCT00001467
43Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?Enrolling by invitationNCT02198521
44Critical Care Excellence in Sepsis and TraumaEnrolling by invitationNCT01426711
45NFIL3-induced Pathological Enhancement of IgE Class Switch Recombination in Hyper-IgE SyndromeNot yet recruitingNCT02228941
46Effect of Different Working Conditions on Risk Factors in Dentists Versus TrainersNot yet recruitingNCT00521235
47A Trial of Clay Weight on the Ear Drum for Patulous Eustachian TubeNot yet recruitingNCT00933478

Search NIH Clinical Center for Hyper-Ige Recurrent Infection Syndrome


Cochrane evidence based reviews: job syndrome

Genetic Tests for Hyper-Ige Recurrent Infection Syndrome

About this section

Genetic tests related to Hyper-Ige Recurrent Infection Syndrome:

id Genetic test Affiliating Genes
1 Autosomal Dominant Hyper Ige Syndrome22 STAT3

Anatomical Context for Hyper-Ige Recurrent Infection Syndrome

About this section

MalaCards organs/tissues related to Hyper-Ige Recurrent Infection Syndrome:

33
Bone, Skin, Lung, Eye, Bone marrow, Heart, Myeloid

Animal Models for Hyper-Ige Recurrent Infection Syndrome or affiliated genes

About this section

MGI Mouse Phenotypes related to Hyper-Ige Recurrent Infection Syndrome:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053977.1CARD9, DOCK8, IRAK4, STAT3, STK4, TYK2
2MP:00053876.8CARD9, DOCK8, IRAK4, STAT3, STK4, TYK2

Publications for Hyper-Ige Recurrent Infection Syndrome

About this section

Articles related to Hyper-Ige Recurrent Infection Syndrome:

idTitleAuthorsYear
1
Characterization of pancreatic ERj3p, a homolog of yeast DnaJ-like protein Scj1p. (15195998)
2004
2
Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system. (8380073)
1993

Variations for Hyper-Ige Recurrent Infection Syndrome

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hyper-Ige Recurrent Infection Syndrome:

67 (show all 14)
id Symbol AA change Variation ID SNP ID
1STAT3p.Arg382LeuVAR_037365
2STAT3p.Arg382GlnVAR_037366
3STAT3p.Arg382TrpVAR_037367
4STAT3p.Phe384LeuVAR_037368
5STAT3p.Phe384SerVAR_037369
6STAT3p.Thr389IleVAR_037370
7STAT3p.Arg423GlnVAR_037371
8STAT3p.His437TyrVAR_037372
9STAT3p.Ser611AsnVAR_037375
10STAT3p.Phe621ValVAR_037376
11STAT3p.Thr622IleVAR_037377
12STAT3p.Val637LeuVAR_037378
13STAT3p.Val637MetVAR_037379
14STAT3p.Tyr657CysVAR_037381

Clinvar genetic disease variations for Hyper-Ige Recurrent Infection Syndrome:

5 (show all 13)
id Gene Variation Type Significance SNP ID Assembly Location
1STAT3NM_139276.2(STAT3): c.1387_1389delGTG (p.Val463del)deletionPathogenicrs113994138GRCh37Chr 17, 40477056: 40477058
2STAT3NM_139276.2(STAT3): c.1144C> T (p.Arg382Trp)single nucleotide variantPathogenicrs113994135GRCh37Chr 17, 40481661: 40481661
3STAT3NM_139276.2(STAT3): c.1145G> A (p.Arg382Gln)single nucleotide variantPathogenicrs113994136GRCh37Chr 17, 40481660: 40481660
4STAT3NM_139276.2(STAT3): c.1268G> A (p.Arg423Gln)single nucleotide variantPathogenicrs113994137GRCh37Chr 17, 40481441: 40481441
5STAT3STAT3, ARG383LEUsingle nucleotide variantPathogenic
6STAT3NM_139276.2(STAT3): c.1909G> A (p.Val637Met)single nucleotide variantPathogenicrs113994139GRCh37Chr 17, 40474492: 40474492
7STAT3NM_139276.2(STAT3): c.1003C> T (p.Arg335Trp)single nucleotide variantLikely pathogenicrs193922716GRCh37Chr 17, 40485737: 40485737
8STAT3NM_139276.2(STAT3): c.1243G> A (p.Glu415Lys)single nucleotide variantLikely pathogenic, Pathogenicrs193922717GRCh37Chr 17, 40481466: 40481466
9STAT3NM_139276.2(STAT3): c.1772A> T (p.Lys591Met)single nucleotide variantLikely pathogenicrs193922719GRCh37Chr 17, 40475138: 40475138
10STAT3NM_139276.2(STAT3): c.1780G> A (p.Glu594Lys)single nucleotide variantLikely pathogenicrs193922720GRCh37Chr 17, 40475130: 40475130
11STAT3NM_139276.2(STAT3): c.1970A> G (p.Tyr657Cys)single nucleotide variantLikely pathogenicrs193922721GRCh37Chr 17, 40474431: 40474431
12STAT3NM_139276.2(STAT3): c.2134T> C (p.Cys712Arg)single nucleotide variantLikely pathogenicrs193922722GRCh37Chr 17, 40469210: 40469210
13STAT3NM_139276.2(STAT3): c.1166C> T (p.Thr389Ile)single nucleotide variantPathogenicrs397514766GRCh37Chr 17, 40481639: 40481639

Expression for genes affiliated with Hyper-Ige Recurrent Infection Syndrome

About this section
Search GEO for disease gene expression data for Hyper-Ige Recurrent Infection Syndrome.

Pathways for genes affiliated with Hyper-Ige Recurrent Infection Syndrome

About this section

Pathways related to Hyper-Ige Recurrent Infection Syndrome according to GeneCards Suite gene sharing:

(show all 19)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.5STAT3, TYK2
2
Show member pathways
9.5STAT3, TYK2
3
Show member pathways
9.5STAT3, TYK2
49.5STAT3, TYK2
59.5STAT3, TYK2
69.5STAT3, TYK2
7
Show member pathways
9.5STAT3, TYK2
89.5STAT3, TYK2
99.5STAT3, TYK2
109.5STAT3, TYK2
119.5STAT3, TYK2
12
Show member pathways
9.5STAT3, TYK2
139.5STAT3, TYK2
149.5STAT3, TYK2
159.5STAT3, TYK2
169.5STAT3, TYK2
179.4IRAK4, STAT3
18
Show member pathways
8.9IRAK4, STAT3, TYK2
19
Show member pathways
8.9IRAK4, STAT3, TYK2

GO Terms for genes affiliated with Hyper-Ige Recurrent Infection Syndrome

About this section

Biological processes related to Hyper-Ige Recurrent Infection Syndrome according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1innate immune responseGO:00450878.8CARD9, IRAK4, TYK2
2protein phosphorylationGO:00064688.2IRAK4, STK4, TYK2

Sources for Hyper-Ige Recurrent Infection Syndrome

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet